FDA approves a fast-acting flu drug that is taken in a single dose
The FDA has approved a flu drug that appears to shut down infection quickly and, unlike anything else on the market, is taken as a single dose.
by Helen Branswell
Oct 24, 2018
2 minutes
The Food and Drug Administration announced Wednesday that it has approved the first new influenza drug with a novel mechanism of action in nearly 20 years. The drug, Xofluza, is being brought to the U.S. market by Genentech, a division of Roche.
The approval comes just in time for flu season, which should begin in earnest in coming weeks.
The drug is a
You’re reading a preview, subscribe to read more.
Start your free 30 days